The induction of tolerance using the brand new gene therapy in transplantation setting and clarification of the mechanism.
在移植环境中使用全新基因疗法诱导耐受并阐明其机制。
基本信息
- 批准号:13470248
- 负责人:
- 金额:$ 9.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. To develop innovative strategies for transplant immunosuppression, we tested the effect of the blockade of costimulatory pathways by using adenovirus vector coding CTLA4Ig(AdCTLA4Ig) or CD40Ig(AdCD40Ig)genes in ACI to LEW rat organ transplantations.A) Heart transplantation : A single treatment with AdCTLA4Ig or AdCD40Ig prolonged graft survival. Although the combined gene therapy allowed long term graft survival, this strategy was not enough to induce tolerance and to avoid chronic rejection.B) Liver transplantation : A single treatment with AdCTLA4Ig or AdCD40Ig prolonged graft survival, and could induce donor-specific tolerance.C) Small bowel transplantation : Although the combined gene therapy prolonged graft survival, this strategy was not enough to induce tolerance and to avoid chronic rejection.D) Xeno heart transplantation(Hamster to Rat) : DXR and cellular rejection were controlled successfully and all xenografts were accepted for over 100 days when AdCTLA4Ig and AdCD40Ig we … More re administered under FK779 induction therapy. However, chronic rejection was inevitable in the long-term surviving xenografts.2. Several strategies have been made in order to avoid the toxicity of adenoviral vector and to establish an efficient and safety gene transfer.A) Ex-vivo transfer : In rat liver transplantation, the graft with 1x10^9pfu AdCTLA4Ig in 4℃ UW solution for more than 8hrs could get efficient transfection rate and tolerance.B) Modified Clamp Technique : Using the short term CT transduction method (under the condition of 4℃ cold preservation for 10 minutes) long term graft survival are achieved.C) Cre/loxP : The administration of adenovirus vector containing Cre recombinase gene(AdexCACre) at the desired time induced Cre-mediated recombination within a gene derived from Adex1CALoxCTLA4IgGLox vector, and the cDNA of CTLA4IgG was excised from the transduced gene and terminated the expression of CTLA4IgG in vitro and in vivo.3. Immunosuppressive mechanism of blockade of CD40-CD 154A) CD40Ig has bi-directional effects, i.e., one direction towards CD4 + T cells that enhances IL-2 production by cross-linking CD40L, and the other to APCs, which results in generation of CD4 + CD25 + T cells. These events, in concert, lead to generation of functional CD4 + CD25 + T cells that regulate CTL activity in an antigen-specific manner. Less
1.为了开发新的移植免疫抑制策略,我们利用携带CTLA4Ig(AdCTLA4Ig)或CD40Ig(AdCD40Ig)基因的腺病毒载体在急性脑梗塞大鼠至LEW大鼠器官移植中测试了阻断共刺激通路的效果。a)心脏移植:单独应用AdCTLA4Ig或AdCD40Ig可延长移植物存活。B)肝移植:单用AdCTLA4Ig或AdCD40Ig可延长移植物存活时间,并可诱导供者特异性免疫耐受。c)小肠移植:虽然联合基因治疗延长了移植物存活时间,但这一策略不足以诱导耐受和避免慢性排斥反应。D)异种心脏移植(仓鼠到大鼠):当AdCTLA4Ig和AdCD40Ig WE…时,DXR和细胞排斥反应被成功控制,所有异种移植都接受了100天以上更多的患者在FK779诱导治疗下再次接受治疗。然而,在长期存活的异种移植物中,慢性排斥是不可避免的。为了避免腺病毒载体的毒性,建立高效、安全的基因转移,人们已经采取了多种策略。A)体外转移:在大鼠肝移植中,在4℃UW溶液中,1x10^9pfu AdCTLA4Ig的移植物在4℃UW溶液中作用8小时以上,可以获得高效的转染率和耐受性。B)改良的夹闭技术:使用短期的CT转导方法(在4 GLx冷保存10分钟的条件下)实现移植物的长期存活。c)Cre/loxP:在所需的时间给予含有Cre重组酶基因的腺病毒载体(AdexCACre)诱导Cre介导的重组从转导基因中切下CTLA4Ig基因,并在体内外终止CTLA4Ig的表达。CD40-CD154A阻断的免疫抑制机制)CD40Ig具有双向作用,即一方面通过CD40L与CD40L相互作用,促进IL-2的产生,另一方面向APC诱导产生CD4+CD25+T细胞。这些事件协同作用,导致产生功能性的CD4+CD25+T细胞,以抗原特异性的方式调节CTL活性。较少
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yanagida N., et al.: "Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation."Transplantation Proceedings. 33(1-2). 573-574 (2001)
Yanagida N. 等人:“在大鼠原位肝移植中用编码 CTLA4Ig 基因的腺病毒载体预处理单个供体的耐受性诱导”。移植论文集。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Echizenya H., et al.: "Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats."Transplantation Proceedings. 33(1-2). 183-184 (2001)
Echizenya H.等人:“大鼠原位小肠移植中腺病毒介导的 CTLA4-IgG 基因治疗。”移植论文集。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yamashita K., et al.: "Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies."Transplantation. 76(7). 1089-1096 (2003)
Yamashita K. 等人:“基于腺病毒介导的 CD40Ig 加 CTLA4Ig 基因疗法,长期接受大鼠同种异体心脏移植。”移植。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nomura M., et al.: "Novel CD40-IgG adenovirus-mediated gene therapy as a potent immunosuppressive treatment for liver transplantation in rats."Transplantation Proceedings. 33(1-2). 189 (2001)
Nomura M.等人:“新型CD40-IgG腺病毒介导的基因疗法作为大鼠肝移植的有效免疫抑制治疗。”移植论文集。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takehara M., et al.: "Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4IgG and loxP."Human Gene Therapy. 12(4). 415-426 (2001)
Takehara M.等人:“通过含有CTLA4IgG和loxP的可调节腺病毒载体的体内基因转移来长期接受同种异体移植。”人类基因治疗。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FURUKAWA Hiroyuki其他文献
FURUKAWA Hiroyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FURUKAWA Hiroyuki', 18)}}的其他基金
High precision determination of intraocular lens power using whole eye segment OCT
利用全眼段OCT高精度测定人工晶状体度数
- 批准号:
26350512 - 财政年份:2014
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of perfusion preservation method of liver graft, aiming to clinical application for liver transplantation using non-heart-beating-donor
开发移植肝灌注保存方法,旨在临床应用无心跳供体肝移植
- 批准号:
23659608 - 财政年份:2011
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Polarization analysis of age-related changes of the crystalline lens with high sensitivity OCT
高灵敏度OCT对晶状体年龄相关变化的偏振分析
- 批准号:
23500529 - 财政年份:2011
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a gene therapy based new strategy in small bowel transplantation
开发基于基因治疗的小肠移植新策略
- 批准号:
16390368 - 财政年份:2004
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of safety methods for adult to adult living donor liver transplantation focused on cyclic AMP signal pathway.
开发成人对成人活体肝移植的安全方法,重点关注环AMP信号通路。
- 批准号:
13557102 - 财政年份:2001
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis for small-for-size liver transplantation ; strategy for safety living donorl liver transplantation in adult
小体积肝移植分析;
- 批准号:
10470250 - 财政年份:1998
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Research on Practical Techniques of Laser Cleaning for Decontaminated Surface of Nuclear Facility
核设施净化表面激光清洗实用技术研究
- 批准号:
10558080 - 财政年份:1998
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Study of the cholesterol transportation mechanism in embryo
胚胎中胆固醇转运机制的研究
- 批准号:
09671672 - 财政年份:1997
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
- 批准号:
MR/Z50385X/1 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
Research Grant
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
- 批准号:
MR/X031039/1 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
- 批准号:
10087446 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
Collaborative R&D
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
- 批准号:
MR/Y019458/1 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
- 批准号:
10090933 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
EU-Funded
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
- 批准号:
2888189 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Studentship
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
- 批准号:
EP/X024563/1 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Research Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
- 批准号:
2240683 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
- 批准号:
23K15643 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
- 批准号:
23K19673 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Research Activity Start-up